Read the Journal of Managed Care + Specialty Pharmacy (JMCP) June 2025 Issue
JMCP Outsert - Non-small Cell Lung Cancer NSCLC (Bridging the Gaps)
FINDINGS FROM THE AMCP MARKET INSIGHTS PROGRAM | July, 2023
Summary
Lung cancer is the most common cancer worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of all lung cancers. The National Institutes of Health estimated that cancer care cost the US $208.9 billion in 2020, $23.8 billion of which was due to lung cancer. View the full fundings from the program on JMCP.
For more disease state research, view the Market Insights Program.
Related
Join us for AMCP Nexus 2025 in National Harbor from October 27-30, 2025. Watch video sizzle reel!
AMCP strongly supports the passage of the MVP Act. Medicaid beneficiaries are among America's most vulnerable patients. Value-based payment arrangements are a critical tool for promoting patient access to high-quality, affordable care.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
